These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2120878)

  • 1. Turnover of thyrotropin-releasing hormone in patients with chronic renal failure and chronic alcoholic liver disease.
    Iversen E; Schmitz O; Laurberg P
    Acta Endocrinol (Copenh); 1990 Aug; 123(2):179-84. PubMed ID: 2120878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of thyrotrophin-releasing hormone in patients in different thyroid states.
    Iversen E
    J Endocrinol; 1991 Jan; 128(1):153-9. PubMed ID: 1900321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and extravascular turnover of thyrotrophin-releasing hormone in normal man.
    Iversen E
    J Endocrinol; 1988 Sep; 118(3):511-6. PubMed ID: 3141551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma clearance and plasma half-disappearance time of exogenous thyrotropin-releasing hormone and pyroglutamyl-N3im-methyl-histidyl prolineamide.
    Morley JE; Garvin TJ; Pekary AE; Utiger RD; Nair MG; Baugh CM; Hershman JM
    J Clin Endocrinol Metab; 1979 Mar; 48(3):377-80. PubMed ID: 107180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin-releasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failure.
    Duntas L; Wolf CF; Keck FS; Rosenthal J
    Clin Nephrol; 1992 Oct; 38(4):214-8. PubMed ID: 1424308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics and pharmacodynamics of protirelin (TRH) in man].
    Duntas L; Keck FS; Loos U; Pfeiffer EF
    Dtsch Med Wochenschr; 1988 Sep; 113(35):1354-7. PubMed ID: 3137012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal response of thyrotrophin and growth hormone to thyrotrophin releasing hormone in chronic renal failure.
    Hasegawa K; Matsushita Y; Otoma S; Hamada N; Nishizawa Y
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):635-43. PubMed ID: 808063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin-releasing hormone degradation in patients with insulin dependent diabetes mellitus. Effects of metabolic control.
    Duntas L; Keck FS; Wolf C; Hauner H; Pfeiffer EF
    Thyroidology; 1991 May; 3(2):51-7. PubMed ID: 1726900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-compartment model analysis of thyrotropin-releasing hormone kinetics in hyper- and hypothyroid patients. Kinetic studies using a combined system of RIA and FPLC.
    Duntas L; Keck FS; Rosenthal J; Wolf C; Loos U; Pfeiffer EF
    Klin Wochenschr; 1990 Oct; 68(20):1013-9. PubMed ID: 2126579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure.
    Pimstone B; Epstein S; Hamilton SM; LeRoith D; Hendricks S
    J Clin Endocrinol Metab; 1977 Feb; 44(2):356-60. PubMed ID: 320223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic mediation of growth hormone secretion induced by thyrotropin-releasing hormone in cirrhotic patients.
    Volpi R; Chiodera P; Cerri L; Roberti G; Salati G; Ferrari P; Delsignore R; Pedretti G; d'Amato L; Coiro V
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):603-8. PubMed ID: 3107300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated basal growth hormone levels and growth hormone response to TRH in alcoholic patients with cirrhosis.
    Zanoboni A; Zanoboni-Muciaccia W
    J Clin Endocrinol Metab; 1977 Sep; 45(3):576-8. PubMed ID: 409728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRH pharmacokinetics and nerve stimulation evoked prostatic fluid secretion during TRH infusion in the dog.
    Liberman C; Nogimori T; Wu CF; Van Buren T; Wilson J; Miller T; Smith E; Emerson CH
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):134-42. PubMed ID: 2492705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of a particulate thyrotropin-releasing hormone-degrading pyroglutamate aminopeptidase activity in rat liver.
    Scharfmann R; Morgat JL; Aratan-Spire S
    Neuroendocrinology; 1989 Apr; 49(4):442-8. PubMed ID: 2566131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans.
    Bassiri RM; Utiger RD
    J Clin Invest; 1973 Jul; 52(7):1616-9. PubMed ID: 4198107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of thyrotropin-releasing hormone (TRH) and deamido-TRH in the rat.
    Safran M; Wu CF; Matys R; Alex S; Emerson CH
    Endocrinology; 1984 Sep; 115(3):1031-7. PubMed ID: 6430680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal developmental pattern of thyrotrophin releasing hormone-degrading activity in rat plasma, hypothalamus and liver: role of tri-iodothyronine.
    Aratan-Spire S; Moilanen K; Czernichow P
    J Endocrinol; 1983 Jun; 97(3):409-18. PubMed ID: 6408215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of exogenous thyrotropin-releasing hormone (TRH) in normal subjects: relationship to endocrine and behavioral effects.
    Loosen PT; Youngblood W; Dew B
    Pharmacopsychiatry; 1985 Nov; 18(6):325-9. PubMed ID: 3937164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TRH response in 53 patients with chronic alcoholism (author's transl)].
    Modigliani E; Periac P; Perret G; Hugues JN; Coste T
    Ann Med Interne (Paris); 1979; 130(5):297-302. PubMed ID: 114079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotrophin releasing hormone and related peptides in canine tissues.
    Pekary AE; Richkind M; Hershman JM
    J Endocrinol; 1983 Sep; 98(3):299-306. PubMed ID: 6413633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.